Patents by Inventor MOMENTA PHARMACEUTICALS, INC.

MOMENTA PHARMACEUTICALS, INC. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130210054
    Abstract: The present disclosure relates to polarized type 2 T helper (Th2) cells and methods for using such cells in the assessment of antigenic compositions.
    Type: Application
    Filed: November 19, 2012
    Publication date: August 15, 2013
    Applicant: Momenta Pharmaceuticals, Inc.
    Inventor: Momenta Pharmaceuticals, Inc.
  • Publication number: 20130184180
    Abstract: The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.
    Type: Application
    Filed: December 19, 2012
    Publication date: July 18, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventor: Momenta Pharmaceuticals, Inc.
  • Publication number: 20130177992
    Abstract: The disclosure features methods of analyzing preparations of heparin, and materials derived from heparin using strong anion exchange high performance liquid chromatography (SAX-HPLC).
    Type: Application
    Filed: December 12, 2012
    Publication date: July 11, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventor: MOMENTA PHARMACEUTICALS, INC.
  • Publication number: 20130095515
    Abstract: Methods for analyzing, selecting, characterizing or classifying compositions of a co-polymer, e.g., glatiramer acetate are described. The methods entail analysis of pyro-glutamate in the composition, and, in some methods, comparing the amount of pyro-glutamate present in a composition to a reference standard.
    Type: Application
    Filed: December 10, 2012
    Publication date: April 18, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventor: Momenta Pharmaceuticals, Inc.
  • Publication number: 20130041176
    Abstract: Methods of analyzing glatiramer acetate (GA) to assess secondary structure, for example, alpha helical content and/or random coil content thereof are provided as are methods for preparing a composition comprising GA and methods for identifying a copolymer as GA.
    Type: Application
    Filed: October 12, 2012
    Publication date: February 14, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventor: MOMENTA PHARMACEUTICALS, INC.
  • Publication number: 20130029365
    Abstract: A multi-dimensional chromatographic method for the separation of N-glycans. The method comprises providing a glycan preparation that includes at least one negatively charged N-glycan. The glycan preparation is then separated by anion-exchange chromatography and at least one secondary chromatographic technique.
    Type: Application
    Filed: September 28, 2012
    Publication date: January 31, 2013
    Applicant: MOMENTA PHARMACEUTICALS, INC.
    Inventor: MOMENTA PHARMACEUTICALS, INC.